Merck & Co., Inc. (MRK) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1157485,
    "name": "Merck & Co., Inc.",
    "stock_name": "Merck & Co., Inc.",
    "full_name": "Merck & Co., Inc.",
    "name_url": "stocks-analysis/merck-co-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "100.89",
    "chg": -1.38,
    "chgp": "-1.35%",
    "dir": -1,
    "prev_price": "102.27",
    "mcapval": "298,482.76",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US58933Y1055",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "5.1 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/merck-co-inc-1157485-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Merck & Co., Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-merck-co-inc-technically-bullish-or-bearish-3673516",
        "imagepath": "",
        "date": "2025-11-05 11:18:33",
        "description": "As of 31 October 2025, the technical trend for Merck & Co., Inc. has changed from mildly bearish to mildly bullish. The current stance is mildly bullish, driven by a mildly bullish MACD on the daily timeframe and mildly bullish moving averages. However, the weekly MACD is mildly bullish while the monthly MACD remains bearish, indicating mixed signals across different timeframes. Additionally, the Dow Theory shows a mildly bearish signal on the weekly chart but is mildly bullish on the monthly chart. \n\nIn terms of performance, Merck has underperformed the S&P 500 across multiple periods, with a year-to-date return of -15.70% compared to the S&P 500's 16.30%, and a one-year return of -17.69% versus 19.89% for the index...."
      },
      {
        "title": "Is Merck & Co., Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-merck-co-inc-technically-bullish-or-bearish-3670715",
        "imagepath": "",
        "date": "2025-11-04 11:29:54",
        "description": "As of 31 October 2025, the technical trend for Merck & Co., Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is mildly bullish, supported by a bullish daily moving average. However, the monthly MACD and KST remain bearish, indicating mixed signals across different time frames. The Bollinger Bands show a mildly bullish stance on the weekly chart but are mildly bearish on the monthly chart. Dow Theory confirms a mildly bullish trend in both weekly and monthly perspectives. \n\nIn terms of performance, Merck has underperformed the S&P 500 across multiple periods, with a year-to-date return of -17.08% compared to the S&P 500's 16.30%, and a one-year return of -19.03% versus 19.89%. Overall, the current technical stance is mildly bullish, but the strength is tempered by bearish indicators on the monthly charts...."
      },
      {
        "title": "Is Merck & Co., Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-merck-co-inc-technically-bullish-or-bearish-3666297",
        "imagepath": "",
        "date": "2025-11-03 11:28:58",
        "description": "As of 31 October 2025, the technical trend for Merck & Co., Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is mildly bullish, while the monthly MACD remains bearish. The daily moving averages indicate a bullish stance, and the weekly KST is bullish, supporting the mildly bullish outlook. However, the monthly indicators, including the Bollinger Bands and KST, are bearish, which tempers the overall strength of the bullish signal. \n\nIn terms of performance, Merck has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -13.57% compared to the S&P 500's 16.30%, and a one-year return of -15.97% versus 19.89% for the index...."
      },
      {
        "title": "Is Merck & Co., Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-merck-co-inc-technically-bullish-or-bearish-3664413",
        "imagepath": "",
        "date": "2025-11-02 11:15:20",
        "description": "As of 31 October 2025, the technical trend for Merck & Co., Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is mildly bullish, supported by a bullish daily moving average. However, the monthly MACD and KST remain bearish, indicating mixed signals across different time frames. The Bollinger Bands show a mildly bullish stance weekly but mildly bearish monthly. Dow Theory aligns with the mildly bullish trend on both weekly and monthly charts. \n\nDespite this mildly bullish outlook, the stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -13.57% compared to the S&P 500's 16.30%, and a one-year return of -15.97% versus 19.89%. Overall, the current stance is mildly bullish but with notable weakness in longer-term performance...."
      },
      {
        "title": "Merck & Co. Experiences Revision in Its Stock Evaluation Amid Strong Financial Fundamentals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/merck-co-changes-valuation-grade-from-fair-to-attractive-amid-stock-price-increase-3640791",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MerckCoInc_valuationdot_3640791.png",
        "date": "2025-10-20 16:31:16",
        "description": "Merck & Co., Inc. has adjusted its valuation, showcasing a P/E ratio of 15 and a price-to-book value of 5.82. The company maintains a strong dividend yield of 5.70% and impressive return metrics, positioning itself competitively within the pharmaceuticals sector despite recent stock performance challenges."
      },
      {
        "title": "Is Merck & Co., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-merck-co-inc-overvalued-or-undervalued-3634266",
        "imagepath": "",
        "date": "2025-10-20 12:19:18",
        "description": "As of 17 October 2025, the valuation grade for Merck & Co., Inc. moved from fair to attractive, indicating a positive shift in its perceived value. The company appears to be undervalued given its P/E ratio of 15, which is lower than the peer average of approximately 26.1 for comparable companies like Johnson & Johnson and Eli Lilly & Co. Additionally, Merck's PEG ratio stands out at 0.03, suggesting strong growth potential relative to its price, while its EV to EBITDA ratio of 11.50 is competitive against peers like Pfizer, which has an EV to EBITDA of 11.07.\n\nIn terms of performance, Merck's recent stock returns have lagged behind the S&P 500, with a year-to-date decline of 14.77% compared to the index's gain of 13.30%. This underperformance, coupled with a robust ROE of 40.02% and a dividend yield of 5.70%, reinforces the narrative that Merck is currently undervalued in the market...."
      },
      {
        "title": "Is Merck & Co., Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-merck-co-inc-overvalued-or-undervalued-3631805",
        "imagepath": "",
        "date": "2025-10-19 11:56:59",
        "description": "As of 17 October 2025, the valuation grade for Merck & Co., Inc. moved from fair to attractive, indicating a more favorable outlook. The company appears undervalued based on its current metrics, with a P/E ratio of 15, a PEG ratio of 0.03, and an EV to EBITDA of 11.50. In comparison to peers, Eli Lilly & Co. has a significantly higher P/E ratio of 40.89, while Pfizer Inc. shows a lower P/E at 14.49, suggesting that Merck is positioned competitively within the industry.\n\nDespite recent stock performance lagging behind the S&P 500, with a year-to-date return of -14.77% compared to the index's 13.30%, the strong fundamentals reflected in a ROE of 40.02% and a dividend yield of 5.70% support the case for Merck being undervalued...."
      },
      {
        "title": "Merck & Co., Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/merck-co-inc-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-decline-3601098",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/MerckCoInc_technicaldot_3601098.png",
        "date": "2025-10-07 20:02:05",
        "description": "Merck & Co., Inc. has recently revised its evaluation amid challenging market conditions. The stock is currently priced at $88.80, reflecting a 19.40% decline over the past year. Technical indicators present a mixed outlook, with varying trends across weekly and monthly assessments, highlighting ongoing performance challenges."
      },
      {
        "title": "Is Merck & Co., Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-merck-co-inc-technically-bullish-or-bearish-3598831",
        "imagepath": "",
        "date": "2025-10-07 12:10:52",
        "description": "As of 3 October 2025, the technical trend for Merck & Co., Inc. has changed from bearish to mildly bearish. The overall stance is mildly bearish, driven by a combination of indicators. The weekly MACD is mildly bullish, while the monthly MACD remains bearish. The Bollinger Bands indicate a bullish signal on the weekly timeframe but are mildly bearish monthly. Moving averages on the daily chart are mildly bearish. Dow Theory shows a mildly bullish stance for both weekly and monthly periods. \n\nIn terms of performance, Merck has outperformed the S&P 500 over the past week and month, with returns of 13.03% and 5.49% respectively, but has significantly underperformed over the year-to-date and one-year periods, with returns of -10.74% and -19.40% compared to the S&P 500's 14.18% and 17.82%...."
      }
    ],
    "total": 19,
    "sid": "1157485",
    "stock_news_url": "https://www.marketsmojo.com/news/merck-co-inc-1157485"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Merck & Co., Inc. technically bullish or bearish?

2025-11-05 11:18:33

As of 31 October 2025, the technical trend for Merck & Co., Inc. has changed from mildly bearish to mildly bullish. The current stance is mildly bullish, driven by a mildly bullish MACD on the daily timeframe and mildly bullish moving averages. However, the weekly MACD is mildly bullish while the monthly MACD remains bearish, indicating mixed signals across different timeframes. Additionally, the Dow Theory shows a mildly bearish signal on the weekly chart but is mildly bullish on the monthly chart. In terms of performance, Merck has underperformed the S&P 500 across multiple periods, with a year-to-date return of -15.70% compared to the S&P 500's 16.30%, and a one-year return of -17.69% versus 19.89% for the index....

Is Merck & Co., Inc. technically bullish or bearish?

2025-11-04 11:29:54

As of 31 October 2025, the technical trend for Merck & Co., Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is mildly bullish, supported by a bullish daily moving average. However, the monthly MACD and KST remain bearish, indicating mixed signals across different time frames. The Bollinger Bands show a mildly bullish stance on the weekly chart but are mildly bearish on the monthly chart. Dow Theory confirms a mildly bullish trend in both weekly and monthly perspectives. In terms of performance, Merck has underperformed the S&P 500 across multiple periods, with a year-to-date return of -17.08% compared to the S&P 500's 16.30%, and a one-year return of -19.03% versus 19.89%. Overall, the current technical stance is mildly bullish, but the strength is tempered by bearish indicators on the monthly charts....

Is Merck & Co., Inc. technically bullish or bearish?

2025-11-03 11:28:58

As of 31 October 2025, the technical trend for Merck & Co., Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is mildly bullish, while the monthly MACD remains bearish. The daily moving averages indicate a bullish stance, and the weekly KST is bullish, supporting the mildly bullish outlook. However, the monthly indicators, including the Bollinger Bands and KST, are bearish, which tempers the overall strength of the bullish signal. In terms of performance, Merck has underperformed against the S&P 500 across multiple time frames, with a year-to-date return of -13.57% compared to the S&P 500's 16.30%, and a one-year return of -15.97% versus 19.89% for the index....

Is Merck & Co., Inc. technically bullish or bearish?

2025-11-02 11:15:20

As of 31 October 2025, the technical trend for Merck & Co., Inc. has changed from mildly bearish to mildly bullish. The weekly MACD is mildly bullish, supported by a bullish daily moving average. However, the monthly MACD and KST remain bearish, indicating mixed signals across different time frames. The Bollinger Bands show a mildly bullish stance weekly but mildly bearish monthly. Dow Theory aligns with the mildly bullish trend on both weekly and monthly charts. Despite this mildly bullish outlook, the stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -13.57% compared to the S&P 500's 16.30%, and a one-year return of -15.97% versus 19.89%. Overall, the current stance is mildly bullish but with notable weakness in longer-term performance....

Merck & Co. Experiences Revision in Its Stock Evaluation Amid Strong Financial Fundamentals

2025-10-20 16:31:16

Merck & Co., Inc. has adjusted its valuation, showcasing a P/E ratio of 15 and a price-to-book value of 5.82. The company maintains a strong dividend yield of 5.70% and impressive return metrics, positioning itself competitively within the pharmaceuticals sector despite recent stock performance challenges.

Is Merck & Co., Inc. overvalued or undervalued?

2025-10-20 12:19:18

As of 17 October 2025, the valuation grade for Merck & Co., Inc. moved from fair to attractive, indicating a positive shift in its perceived value. The company appears to be undervalued given its P/E ratio of 15, which is lower than the peer average of approximately 26.1 for comparable companies like Johnson & Johnson and Eli Lilly & Co. Additionally, Merck's PEG ratio stands out at 0.03, suggesting strong growth potential relative to its price, while its EV to EBITDA ratio of 11.50 is competitive against peers like Pfizer, which has an EV to EBITDA of 11.07. In terms of performance, Merck's recent stock returns have lagged behind the S&P 500, with a year-to-date decline of 14.77% compared to the index's gain of 13.30%. This underperformance, coupled with a robust ROE of 40.02% and a dividend yield of 5.70%, reinforces the narrative that Merck is currently undervalued in the market....

Is Merck & Co., Inc. overvalued or undervalued?

2025-10-19 11:56:59

As of 17 October 2025, the valuation grade for Merck & Co., Inc. moved from fair to attractive, indicating a more favorable outlook. The company appears undervalued based on its current metrics, with a P/E ratio of 15, a PEG ratio of 0.03, and an EV to EBITDA of 11.50. In comparison to peers, Eli Lilly & Co. has a significantly higher P/E ratio of 40.89, while Pfizer Inc. shows a lower P/E at 14.49, suggesting that Merck is positioned competitively within the industry. Despite recent stock performance lagging behind the S&P 500, with a year-to-date return of -14.77% compared to the index's 13.30%, the strong fundamentals reflected in a ROE of 40.02% and a dividend yield of 5.70% support the case for Merck being undervalued....

Merck & Co., Inc. Experiences Evaluation Revision Amid Mixed Market Performance Indicators

2025-10-07 20:02:05

Merck & Co., Inc. has recently revised its evaluation amid challenging market conditions. The stock is currently priced at $88.80, reflecting a 19.40% decline over the past year. Technical indicators present a mixed outlook, with varying trends across weekly and monthly assessments, highlighting ongoing performance challenges.

Is Merck & Co., Inc. technically bullish or bearish?

2025-10-07 12:10:52

As of 3 October 2025, the technical trend for Merck & Co., Inc. has changed from bearish to mildly bearish. The overall stance is mildly bearish, driven by a combination of indicators. The weekly MACD is mildly bullish, while the monthly MACD remains bearish. The Bollinger Bands indicate a bullish signal on the weekly timeframe but are mildly bearish monthly. Moving averages on the daily chart are mildly bearish. Dow Theory shows a mildly bullish stance for both weekly and monthly periods. In terms of performance, Merck has outperformed the S&P 500 over the past week and month, with returns of 13.03% and 5.49% respectively, but has significantly underperformed over the year-to-date and one-year periods, with returns of -10.74% and -19.40% compared to the S&P 500's 14.18% and 17.82%....

View All News